This year, medical device manufacturers are rising to the COVID-19 challenge by developing innovative new products. For example, industry leaders such as Johnson & Johnson and Abbott Laboratories are doing their part to develop PPE to protect healthcare workers around the globe.
What else do top medical device manufacturers have planned this year? Let's take a look.
Medical Device Manufacturers Changing Life Sciences in 2020
We understand how important it is to optimize your quality management processes. As an industry-leading enterprise quality management software (eQMS) provider, we understand the importance of uniting your teams, processes, and data so you can get your products to market quickly.
For this reason, we've developed a quick assessment to help you discover any cracks that might exist in your quality management process. Additionally, you could even model your approach toward product development and quality management after these top medical device manufacturers.
Johnson & Johnson has been a major player in the healthcare industry for over 130 years. They have more than 130,000 employees, and they work side-by-side with entrepreneurs to help improve people’s lives with healthcare solutions.
With the threat of COVID-19 disrupting the lives of every U.S. citizen, Johnson & Johnson stepped up to the plate by working on a vaccine to combat and eradicate the virus. In fact, J&J recently partnered with the U.S. Department of Health and Human Services with the promise of manufacturing and distributing 1 billion vaccines worldwide.
Abbott Laboratories has been in business for over 130 years, and they have more than 107,000 workers in over 160 countries. The company is a market leader in glucose monitoring, blood and plasma screening, adult nutrition, pediatric nutrition, heart pumps, remote heart failure monitoring, point of care testing, and chronic pain devices. With the pressure on to ramp up testing, Abbot Laboratories rose to the challenge and created a new 5-minute test for COVID-19.
3. Novartis AG
Novartis AG is comprised of two separate businesses: Novartis Pharmaceuticals and Novartis Oncology. The units provide innovative medicines to help treat patients and improve the quality of care that healthcare professionals can offer.
Novartis has its team ramping up clinical trials in search of an effective and safe treatment that can be administered to patients suffering from COVID-19 symptoms.
They are currently undergoing trials for the drug Jakavi® (ruxolitinib) to help patients who are experiencing cytokine storm, which is when the immune system has a severe overreaction to the virus and causes increased respiratory complications in COVID-19 patients.
Medtronic has more than 350 locations in over 150 countries, and they currently have over 86,000 employees. The company focuses on providing value-based healthcare to its patients by prioritizing higher quality, more integrated, lower-cost care. Medtronic is working on protecting healthcare workers and their patients by ramping up production on ventilators, pulse oximeters, and ECMO products.
The company has even adapted their Medtronic Care Management Services to make it possible for patients to receive remote care and monitoring.
Thanks to Medtronic and other companies providing similar services, remote healthcare isn’t likely to go away anytime soon. The convenience and lower costs associated with this method of assessing and monitoring patients will ensure that this practice is here to stay.
Uncover Cracks in Your Quality Management Process
This year, medical device manufacturers promise to reimagine life sciences.
To keep pace, we recommend taking our free quality assessment. Simply answer the 20 multiple-choice questions included in the assessment, and we’ll give you a numerical score that ranges from 0–76. Your target goal is to get a score of 60 or higher. The assessment only takes a few minutes, and it could save you a lot of time and money in the long run by showing you where your processes are lacking and how you can improve them.
“We now have a Quality Management System that is fully compliant for class III medical devices. With Qualio, we are prepared to take the next steps towards compliance with European regulatory requirements and the CE mark.” — Cardiaccs AS
“Using Qualio as part of our overall quality improvement efforts, we were able to get SOC Type II certified in about a year and a half, which is very impressive.” — Colin Rhodes, CTO of eHealth Technologies